Your browser doesn't support javascript.
loading
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer.
Puglisi, Fabio; Gerratana, Lorenzo; Lambertini, Matteo; Ceppi, Marcello; Boni, Luca; Montemurro, Filippo; Russo, Stefania; Bighin, Claudia; De Laurentiis, Michelino; Giuliano, Mario; Bisagni, Giancarlo; Durando, Antonio; Turletti, Anna; Garrone, Ornella; Ardizzoni, Andrea; Gamucci, Teresa; Colantuoni, Giuseppe; Gravina, Adriano; De Placido, Sabino; Cognetti, Francesco; Del Mastro, Lucia.
Afiliación
  • Puglisi F; Department of Medicine (DAME), University of Udine, Udine, Italy. fabio.puglisi@uniud.it.
  • Gerratana L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy. fabio.puglisi@uniud.it.
  • Lambertini M; Department of Medicine (DAME), University of Udine, Udine, Italy.
  • Ceppi M; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano (PN), Italy.
  • Boni L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy.
  • Montemurro F; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Russo S; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Bighin C; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • De Laurentiis M; Day Hospital Oncologico Multidisciplinare, Istituto di Candiolo, FPO-IRCCS, Candiolo, Italy.
  • Giuliano M; Department of Oncology, ASU FC University Hospital, Udine, Italy.
  • Bisagni G; Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Durando A; Department of Breast Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Italy.
  • Turletti A; Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  • Garrone O; AUSL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Ardizzoni A; Breast Unit Ospedale S Anna, Citta' della Salute e della Scienza di Torino, Torino, Italy.
  • Gamucci T; Breast Unit, ASL Citta' di Torino, Torino, Italy.
  • Colantuoni G; Breast Unit, Department of Medical Oncology AO S. Croce e Carle Ospedale di Insegnamento, Cuneo, Italy.
  • Gravina A; Medical Oncology, S.Orsola University Hospital, Bologna, Italy.
  • De Placido S; Department of Medical Oncology, Sandro Pertini Hospital and S. Eugenio Hospital, ASL Roma2, Roma, Italy.
  • Cognetti F; Medical Oncology, Azienda Ospedaliera S Giuseppe Moscati, Avellino, Italy.
  • Del Mastro L; Clinical Trial Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Napoli, Italy.
NPJ Breast Cancer ; 7(1): 82, 2021 Jun 28.
Article en En | MEDLINE | ID: mdl-34183674
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: NPJ Breast Cancer Año: 2021 Tipo del documento: Article País de afiliación: Italia